3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
2
Urinary Bladder Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
16
Etoposide
14
Carboplatin
11
Temozolomide
10
Vincristine
9
Granulocyte Colony-Stimulating Factor
9
Filgrastim
9
Magnetic Resonance Spectroscopy
8
Cisplatin
8
etoposide phosphate
7
X-Rays
7
Thiotepa
7
Phantoms, Imaging
7
Methotrexate
7
Topotecan
6
Specimen Handling
6
Radiotherapy
6
tazemetostat
5
Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
fludarabine
4
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Melphalan
4
Biopsy
4
palbociclib
3
Sirolimus
3
Nivolumab
3
Leucovorin
3
Irinotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Rhabdoid Tumor
×
gallium maltolate
×
Clear all
NCT07331064
2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1
Not yet recruiting
15 enrolled